Ritha Njau

Evidence of artemisinin partial resistance in northwestern Tanzania: clinical and molecular markers of resistance

Deus S. Ishengoma, Celine I. Mandara, Catherine Bakari et al. · The Lancet Infectious Diseases · 2024 · 99 citations · Full text

Veterinary Medicine, Infectious Diseases, Pharmacology +17

Efficacy and safety of artemisinin-based combination therapy, and molecular markers for artemisinin and piperaquine resistance in Mainland Tanzania

Mwaka A. Kakolwa, Muhidin K. Mahende, Deus S. Ishengoma et al. · Malaria Journal · 2018 · 92 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +15

Efficacy and safety of artemether-lumefantrine for the treatment of uncomplicated malaria and prevalence of Pfk13 and Pfmdr1 polymorphisms after a decade of using artemisinin-based combination therapy in mainland Tanzania

Celine I. Mandara, Filbert Francis, Eldin Talundzic et al. · Malaria Journal · 2019 · 82 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +14

Describing the current status of <i>Plasmodium falciparum</i> population structure and drug resistance within mainland Tanzania using molecular inversion probes

Kara A. Moser, Rashid A. Madebe, Özkan Aydemir et al. · Molecular Ecology · 2020 · 78 citations · Full text

Veterinary Medicine, Infectious Diseases, Molecular Genetics +15

Susceptibility status of malaria vectors to insecticides commonly used for malaria control in Tanzania

Bilali Kabula, Patrick Tungu, Johnson Matowo et al. · Tropical Medicine & International Health · 2012 · 67 citations

Life Sciences, Entomology, Infectious Diseases +12